Andreas Reichel

Person

Berlin, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Anthranilamide pyridinureas as vascular endothelial growth factor (...
- Patent number 7,902,229
- Issue date Mar 8, 2011
- Bayer Schering Pharma AG
- Rolf Bohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-androgenic pyrrolidines with tumor-inhibiting action
- Patent number 7,601,748
- Issue date Oct 13, 2009
- Bayer Schering Pharma AG
- Arwed Cleve
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
17α-alkyl-17β-oxy-estratrienes and intermediate products for their...
- Patent number 7,538,100
- Issue date May 26, 2009
- Bayer Schering Pharma Aktiengesellschaft
- Rolf Bohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-androgenic pyrrolidines with tumor-inhibiting action
- Patent number 7,138,421
- Issue date Nov 21, 2006
- Schring Aktiengesellschaft
- Arwed Cleve
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR...
- Patent number 7,018,994
- Issue date Mar 28, 2006
- Schering AG
- Rolf Bohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperazine derivatives that destabilize androgen receptors
- Patent number 6,861,432
- Issue date Mar 1, 2005
- Schering Aktiengesellschaft
- Arwed Cleve
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FA...
- Publication number 20110124680
- Publication date May 26, 2011
- Rolf BOHLMANN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-androgenic pyrrolidines with tumor-inhibiting action
- Publication number 20070021481
- Publication date Jan 25, 2007
- Arwed Cleve
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel anthranilamide pyridinureas as vascular endothelial growth fa...
- Publication number 20060116380
- Publication date Jun 1, 2006
- Rolf Bohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for...
- Publication number 20060009436
- Publication date Jan 12, 2006
- Rolf Bohlmann
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Anti-androgenic pyrrolidines with tumor-inhibiting action
- Publication number 20050159468
- Publication date Jul 21, 2005
- Arwed Cleve
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical preparations, use of these preparations and process...
- Publication number 20040223983
- Publication date Nov 11, 2004
- Philip Lienau
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Piperazine derivatives that destabilize androgen receptors
- Publication number 20040009969
- Publication date Jan 15, 2004
- Schering AG
- Arwed Cleve
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for...
- Publication number 20030191099
- Publication date Oct 9, 2003
- Schering AG
- Rolf Bohlmann
- C07 - ORGANIC CHEMISTRY

Andreas Reichel

Person

Patents Grantslast 30 patents

Anthranilamide pyridinureas as vascular endothelial growth factor (...

Anti-androgenic pyrrolidines with tumor-inhibiting action

17α-alkyl-17β-oxy-estratrienes and intermediate products for their...

Anti-androgenic pyrrolidines with tumor-inhibiting action

17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR...

Piperazine derivatives that destabilize androgen receptors

Patents Applicationslast 30 patents

NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FA...

Anti-androgenic pyrrolidines with tumor-inhibiting action

Novel anthranilamide pyridinureas as vascular endothelial growth fa...

17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for...

Anti-androgenic pyrrolidines with tumor-inhibiting action

Pharmaceutical preparations, use of these preparations and process...

Piperazine derivatives that destabilize androgen receptors

17alpha-alkyl-17beta-oxy-estratrienes and intermediate products for...